APDN Reminds Shareholders to Vote Ahead of Special Meeting on February 14
February 11th, 2025
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Corporate/Financial News
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
January 8th, 2025
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
December 17th, 2024
APDN to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
December 16th, 2024
APDN Announces $3.44M Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 31st, 2024
APDN Schedules FY2’21 Financial Results Conference Call and Webcast for Thursday, May 13, 2021
May 7th, 2021
APDN Quarterly Revenues Increase 138% Year over Year in FQ2’15
May 12th, 2015